Axinn Advised Columbia Care in its $240M Acquisition of Green Leaf Medical
May 3, 2021
Axinn represented Columbia Care, a market leader in the two largest cannabis markets in the world (California and Colorado) in its acquisition of Green Leaf Medical, a privately held, fully-integrated cannabis multi-state operator based in the mid-Atlantic region for $240 million with the potential for additional performance-based milestone payments. Announced on December 22, 2020, the acquisition of Green Leaf will expand Columbia Care’s operational scale and footprint in four key, limited license markets by materially enhancing the scale and capabilities of its seed-to-sale operations. The deal closed on June 11, 2021.
The Axinn team was led by Lisl Dunlop and assisted by associate Sam Sherman.
To subscribe to our publications, click here.
Featured Insights
Featured Insights
GCR Live: Law Leaders Europe 2025
Speaking Engagement
Antitrust
Navigating Compliance: How the 2025 Hart-Scott-Rodino Updates Are Impacting Businesses
Webinar
Antitrust
AHLA Annual Meeting 2025
Speaking Engagement
Antitrust
SABA North America Annual Conference 2025
Speaking Engagement
Antitrust
Volunteer Lawyers for the Arts – Champions of the Arts Awards and Gala 2025
Sponsorship
Antitrust
Washington Lawyers’ Committee for Civil Rights and Urban Affairs – 2025 Wiley A. Branton Awards Luncheon
Sponsorship
Antitrust
What's Happening in Germany and Portugal? Catching Up With International Enforcers at the 2025 Spring Meeting
Podcast
Antitrust
Partner Jason Murata Appointed to the Board of Directors of the National LGBTQ+ Bar Association
Workplace Culture & Opportunity
Managing Partner Jeny Maier Named to Global Competition Review's Women in Antitrust
Awards & Recognitions
Antitrust
Axinn Partners Named to WIPR's Leaders 2025 Directory
Awards & Recognitions
Intellectual Property